BioSpace News Archive

Valens GroWorks Corp., a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has entered into an arm’s length binding multi-year extraction services agreement to provide cannabis extraction services to Tantalus Labs, a leading British-Columbia-based cannabis producer.

The company is commercializing its FDA-cleared bio-ConneKt® Wound Matrix to the advance wound care market.

Mallinckrodt plc announced updated plans for its spin-off of a new company consisting of Mallinckrodt’s Specialty Generics/Active Pharmaceutical Ingredients business to Mallinckrodt plc shareholders.

BioMarin Pharmaceutical Inc. announced that its investigational gene therapy, valoctocogene roxaparvovec, for adults with severe hemophilia A achieved pre-specified clinical criteria for regulatory review in the U.S. and Europe.

TransEnterix, Inc. announced that it has received Japanese regulatory approval for the Senhance™ Surgical System.

BioMarin Pharmaceutical Inc. announced an update to its previously reported results of an open-label Phase 1/2 study of valoctocogene roxaparvovec, an investigational gene therapy treatment for adults with severe hemophilia A.

Unsmoke Campaign and www.unsmoke.ca Launch Ahead of World No Tobacco Day on May 3

As a leader in laser tattoo removal, hair removal, and other aesthetic procedures, Astanza is hosting an educational workshop during the Vegas Cosmetic Surgery 2019 Symposium to introduce attendees to their latest technology, the Astanza EthereaMX platform laser.

Soligenix, Inc. announced that Soligenix will be participating in a biodefense contract for the development of medical countermeasures against bacterial threat agents, with Soligenix awarded a subcontract of approximately $600,000 over 3 years.

TerrAscend Corp. has completed its previously announced upsized non-brokered private placement with orders totaling approximately $69 million.